Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Operative and postoperative data.

From: Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial)

  Group 1 Group 2 P value
ACT (A) value 128 ± 18 132 ± 16 NS
ACT (after protamine) 138 ± 24 143 ± 32 NS
Aortic cross clamp duration (min) 85 ± 11 90 ± 13 NS
Cardiopulmonary bypass duration (min) 100 ± 23 108 ± 25 NS
Prime solution amount (ml) 1500 1500 NS
Fluid added to the pump during CPB (ml) 1360 ± 360 0 0.0001*
Net balance at the pump outlet (ml) 1515 ± 270 590 ± 100 0.0001*
Postoperative blood transfusion (units) 2 2 NS
Postoperative FFP transfusion (units) 2 2 NS
Postoperative drainage (ml) 460 ± 140 430 ± 150 NS
Extubation time (hour) 10 ± 4 9 ± 4,5 NS
Intensive care stay (hour) 47 ± 12 45 ± 10 NS
Creatine clearance at postoperative 72nd hour 68 ± 15 64 ± 15 NS
Discharge time (days) 9 ± 3 8 ± 3 NS
  1. ACT: Active coagulation time; CPB: Cardiopulmonary bypass; FFP: Fresh frozen plasma; NS: Not significant (p > 0.05).